BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 3:07:00 PM | Browse: 1406 | Download: 1126
Publication Name World Journal of Obstetrics and Gynecology
Manuscript ID 2434
Country Italy
Received
2013-02-21 09:47
Peer-Review Started
2013-02-21 20:18
To Make the First Decision
2013-04-16 09:13
Return for Revision
2013-04-18 15:32
Revised
2013-04-23 07:12
Second Decision
2013-07-11 08:18
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-07-11 12:59
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-09-10 15:49
Publish the Manuscript Online
2013-11-17 20:09
ISSN 2218-6220 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Obstetrics & Gynecology
Manuscript Type Autobiography
Article Title Cytoreductive surgery and HIPEC after neoadjuvant chemotherapy for advanced epithelial ovarian cancer
Manuscript Source Invited Manuscript
All Author List Marco Lotti, Luisa Maria Busci, Luca Campanati, Fausto Catena, Federico Coccolini, Naoual Bakrin, Pierandrea De Iaco, Giorgio Ercolani, Giuseppe Grosso, Michele Pisano, Elia Poiasina, Diego Rossetti, Martina Rossi, Claudio Zamagni, Paolo Bertoli, Antonio Daniele Pinna, Luigi Frigerio and Luca Ansaloni
Funding Agency and Grant Number
Corresponding Author Dr. Luca Ansaloni, MD, Unit of General Surgery 1, Papa Giovanni XXIII Hospital, Piazza OMS, Organizzazione mondiale della sanità 1, 24128 Bergamo, Italy. lansaloni@hpg23.it
Key Words Peritoneal carcinomatosis; Ovarian cancer; Cytoreductive surgery; Intraperitoneal chemotherapy; Hyperthermic intraperitoneal chemotherapy; Hyperthermia
Core Tip This is a report of a phase 2 prospective observational study, which served as a pilot study for the CHORINE trial protocol (http://www.chorine.org). Our pilot study supports the feasibility of neoadjuvant chemotherapy (NACT) followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for upfront treatment of advanced epithelial ovarian cancer. This combined therapy does not reduce the possibility to start the postoperative systemic chemotherapy in an acceptable period of time. We believe that in the upfront setting NACT can better select chemoresponsive patients, increasing their chance to take advantage from HIPEC, reducing the surgical stress and the perioperative complications.
Publish Date 2013-11-17 20:09
Citation Lotti M, Busci LM, Campanati L, Catena F, Coccolini F, Bakrin N, De Iaco P, Ercolani G, Grosso G, Pisano M, Poiasina E, Rossetti D, Rossi M, Zamagni C, Bertoli P, Pinna AD, Frigerio L, Ansaloni L. Cytoreductive surgery and HIPEC after neoadjuvant chemotherapy for advanced epithelial ovarian cancer. World J Obstet Gynecol 2013; 2(4): 167-175
URL http://www.wjgnet.com/2218-6220/full/v2/i4/167.htm
DOI http://dx.doi.org/10.5317/wjog.v2.i4.167
Full Article (PDF) WJOG-2-167.pdf
Manuscript File 2434-Review.doc
Answering Reviewers 2434-Answering reviewers.pdf
Copyright License Agreement 2434-Copyright assignment.pdf
Peer-review Report 2434-Peer review(s).pdf
Scientific Editor Work List 2434-Scientific editor work list.doc